Volume 10, Issue 3 (7-2024)
Journal of Research in Applied and Basic Medical Sciences 2024, 10(3): 299-309 |
Back to browse issues page
Ethics code: IR.HUMS.REC.1398.476
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rahimi M, Samimagham H R, Salimi Asl A, Sheybani-Arani M, Khajavi-Mayvan F, Boushehri E, et al . Evaluating the effect of thyroid disorders in hemodialysis patients. Journal of Research in Applied and Basic Medical Sciences 2024; 10 (3) :299-309
URL: http://ijrabms.umsu.ac.ir/article-1-311-en.html
URL: http://ijrabms.umsu.ac.ir/article-1-311-en.html
Mahshad Rahimi 
, Hamid Reza Samimagham , Ali Salimi Asl , Mohammadhosein Sheybani-Arani , Fatemeh Khajavi-Mayvan , Elham Boushehri , Ladan Hajiabdolrassouli , Mitra Kazemi Jahromi *
, Hamid Reza Samimagham , Ali Salimi Asl , Mohammadhosein Sheybani-Arani , Fatemeh Khajavi-Mayvan , Elham Boushehri , Ladan Hajiabdolrassouli , Mitra Kazemi Jahromi *
Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandarabbas, Iran , mitra.kazemijahromi@gmail.com
Abstract: (163 Views)
Background & Aims: The thyroid gland, a small butterfly-shaped organ in the neck, regulates the body’s metabolism. Disruptions in its function can lead to various health issues, including fatigue, weight changes, and cardiovascular problems. In hemodialysis patients, thyroid function is even more crucial. Hemodialysis, a treatment for kidney failure, filters waste and excess fluid from the blood, potentially affecting various bodily systems, including the endocrine system. This study examines the effect of thyroid function on hemodialysis.
Materials & Methods: In this descriptive-analytical study, dialysis patients were classified into three groups: hypothyroid, hyperthyroid, and euthyroid. The levels of thyroid and parathyroid hormones, serum electrolytes, clinical symptoms, laboratory results, and blood pressure of the patients in these groups were compared.
Results: There was no significant difference between the number of dialysis sessions and thyroid function. The serum calcium level was significantly higher in hypothyroid patients than in euthyroid and hyperthyroid patients. There were no significant differences in weight changes before and after dialysis considering the participants’ sex and age (P = 0.227 and P = 0.457). Moreover, there were no significant differences in the number of dialysis sessions (P = 0.508), systolic (P = 0.419), and diastolic blood pressure (P = 0.559), or in the serum level of parathormone in patients with different thyroid functions (P = 0.103). However, the serum level of phosphorus was significantly higher in hyperthyroid patients than in normal patients and lower than in hypothyroid patients (P = 0.049). The hemoglobin concentration was higher in hyperthyroid patients than in other groups (P = 0.021).
Conclusion: The changes in calcium, hemoglobin, and parathormone levels in hemodialysis patients with different thyroid function statuses showed significant differences. These differences are believed to be caused by high bone metabolism in dialysis patients. Evaluating these parameters in dialysis patients is recommended, highlighting the need for regular thyroid function screening among these patients.
Materials & Methods: In this descriptive-analytical study, dialysis patients were classified into three groups: hypothyroid, hyperthyroid, and euthyroid. The levels of thyroid and parathyroid hormones, serum electrolytes, clinical symptoms, laboratory results, and blood pressure of the patients in these groups were compared.
Results: There was no significant difference between the number of dialysis sessions and thyroid function. The serum calcium level was significantly higher in hypothyroid patients than in euthyroid and hyperthyroid patients. There were no significant differences in weight changes before and after dialysis considering the participants’ sex and age (P = 0.227 and P = 0.457). Moreover, there were no significant differences in the number of dialysis sessions (P = 0.508), systolic (P = 0.419), and diastolic blood pressure (P = 0.559), or in the serum level of parathormone in patients with different thyroid functions (P = 0.103). However, the serum level of phosphorus was significantly higher in hyperthyroid patients than in normal patients and lower than in hypothyroid patients (P = 0.049). The hemoglobin concentration was higher in hyperthyroid patients than in other groups (P = 0.021).
Conclusion: The changes in calcium, hemoglobin, and parathormone levels in hemodialysis patients with different thyroid function statuses showed significant differences. These differences are believed to be caused by high bone metabolism in dialysis patients. Evaluating these parameters in dialysis patients is recommended, highlighting the need for regular thyroid function screening among these patients.
Type of Study: orginal article |
Subject:
Special
References
1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013 Jul 20;382(9888):260-72. doi: 10.1016/S0140-6736(13)60687-X. [DOI:10.1016/S0140-6736(13)60687-X] [PMID]
2. Praw SS, Way JSA, Weiss R. Evaluating Thyroid Function Tests in Patients with Kidney Disease. Endocrine Disorders in Kidney Disease: Springer; 2019. p. 85-96. [DOI:10.1007/978-3-319-97765-2_7]
3. Wiederkehr MR, Kalogiros J, Krapf R. Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transplant 2004 May;19(5):1190-7. doi: 10.1093/ndt/gfh096. [DOI:10.1093/ndt/gfh096] [PMID]
4. Rhee CM, You AS, Nguyen DV, Brunelli SM, Budoff MJ, Streja E, et al. Thyroid Status and Mortality in a Prospective Hemodialysis Cohort. J Clin Endocrinol Metab 2017 May 1;102(5):1568-1577. doi: 10.1210/jc.2016-3616. [DOI:10.1210/jc.2016-3616] [PMID] []
5. Napolitano G, Bonomini M, Bomba G, Bucci I, Todisco V, Albertazzi A, Monaco F. Thyroid function and plasma selenium in chronic uremic patients on hemodialysis treatment. Biol Trace Elem Res. 1996 Dec;55(3):221-30. doi: 10.1007/BF02785281. [DOI:10.1007/BF02785281] [PMID]
6. Schomburg L. Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nat Rev Endocrinol. 2011 Oct 18;8(3):160-71. doi: 10.1038/nrendo.2011.174. [DOI:10.1038/nrendo.2011.174] [PMID]
7. Takeda S, Michigishi T, Takazakura E. Iodine-induced hypothyroidism in patients on regular dialysis treatment. Nephron. 1993;65(1):51-5. doi: 10.1159/000187440. [DOI:10.1159/000187440] [PMID]
8. Rhee CM, Alexander EK, Bhan I, Brunelli SM. Hypothyroidism and mortality among dialysis patients. Clin J Am Soc Nephrol. 2013 Apr;8(4):593-601. doi: 10.2215/CJN.06920712. [DOI:10.2215/CJN.06920712] [PMID] []
9. Bin Saleh FS, Naji MN, Eltayeb AA, Hejaili FF, Al Sayyari AA. Effect of thyroid function status in hemodialysis patients on erythropoietin resistance and interdialytic weight gain. Saudi J Kidney Dis Transpl. 2018;29(6):1274-9. [DOI:10.4103/1319-2442.248310] [PMID]
10. Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P, et al. Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. Journal of hypertension. 2006;24(10):2039-46. [DOI:10.1097/01.hjh.0000244954.62362.8f] [PMID]
11. Thomas E CCJ, Robert C, et al. Griggs cecil essentials of medicine2001. [URL]
12. Tatar E, Kircelli F, Asci G, Carrero JJ, Gungor O, Demirci MS, et al. Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients. Clinical Journal of the American Society of Nephrology 2011;6(9):2240-6. [DOI:10.2215/CJN.02540311] [PMID] []
13. Dahiya K, Verma M, Dhankhar R, Ghalaut V, Ps G, Sachdeva A, et al. Thyroid profile and iron metabolism: mutual relationship in hypothyroidism. Biomedical Research-tokyo 2016;27:1212-5. [GOOGLE SCHOLAR]
14. Ipek I KE, Bozaykut A, Sezer RJ, Seren L, Paketçi C. The effect of iron deficiency anaemia on plasma thyroid hormone levels in childhood. Turk Arch Ped 2011. [GOOGLE SCHOLAR]
15. Geetha J, Srikrishna R. Role of red blood cell distribution width (rdw) in thyroid dysfunction. Int J Biol Med Res 2012;3(2): 1476-478. [GOOGLE SCHOLAR]
16. Łebkowska U, Malyszko J, Myśliwiec M. Thyroid function and morphology in kidney transplant recipients, hemodialyzed, and peritoneally dialyzed patients. Transplant Proc. 2003 Dec;35(8):2945-8. doi: 10.1016/j.transproceed.2003.10.066. [DOI:10.1016/j.transproceed.2003.10.066] [PMID]
17. Sennesael JJ, Verbeelen DL, Jonckheer MH. Thyroid dysfunction in patients on regular hemodialysis: evaluation of the stable intrathyroidal iodine pool, incidence of goiter and free thyroid hormone concentration. Nephron. 1985;41(2):141-5. doi: 10.1159/000183569. [DOI:10.1159/000183569] [PMID]
18. Depner T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek J, Levin N, Macon E, Milford E, Owen W, Star R, Toto R, Eknoyan G; Hemodialysis Study Group. Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int. 2004 Apr;65(4):1386-94. doi: 10.1111/j.1523-1755.2004.00519.x. [DOI:10.1111/j.1523-1755.2004.00519.x] [PMID]
19. Port FK, Wolfe RA, Hulbert-Shearon TE, McCullough KP, Ashby VB, Held PJ. High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis. 2004 Jun;43(6):1014-23. doi: 10.1053/j.ajkd.2004.02.014. [DOI:10.1053/j.ajkd.2004.02.014] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Contact Information
Address: Urmia University of Medical Sciences, Jahad Ave., Urmia, I.R. Iran. Post code: 57147-83734. P.O. Box. 1138
Email: ijrabms
gmail.com
rabmsumsu.ac.ir
Tel / Fax: +984431937332/+984432240642
